Authors
Loading...
Observational analysis finds high infection risk in multiple myeloma patients treated with bispecific antibodies, suggesting immunoglobulin replacement may reduce infection burden.
Kastritis et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: